Background Endocarditis has emerged as one of the most impactful adverse events after
transcatheter pulmonary valve replacement (TPVR), but there is limited information about …

Background Transcatheter pulmonary valve (TPV) replacement (TPVR) has become the
standard therapy for postoperative pulmonary outflow tract dysfunction in patients with a …

Objectives Accurate sizing of the left atrial appendage (LAA) is essential when performing
percutaneous LAA closure. This study aimed to compare different LAA imaging modalities …

Transcatheter aortic valve replacement (TAVR) has become an established therapeutic
option for patients with symptomatic, severe aortic stenosis. The optimal treatment strategy …

Aims: Transcatheter aortic valve implantation (TAVI) is an established therapy for patients
with severe aortic stenosis (AS). The aim of this study was to evaluate the newer-generation …

A42-year-old female patient who presented to the emergency department with catastrophic
antiphospholipid syndrome manifested by stroke, acute renal failure, and liver failure …

In March 2015, the US Food and Drug Administration approved left atrial appendage (LAA)
occlusion with the Watchman device (Boston Scientific Corp., Marlborough, Massachusetts) …

A67-year-old man was admitted to the emergency department with a 2-day history of
headache, nausea, and left-hand weakness. On physical examination, his blood pressure …

Background: This study aimed to compare different pre-procedural left atrial appendage
(LAA) imaging modalities and analyze the anatomical adaptation of the LAA to the closure …

Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an
established therapy for high/intermediate-risk patients with severe symptomatic aortic …